Piper Jaffray Downgrades BioMarin Pharmaceutical Inc. (BMRN) to Neutral

November 7, 2016 7:15 AM EST
Get Alerts BMRN Hot Sheet
Price: $84.62 -1.78%

Rating Summary:
    20 Buy, 6 Hold, 0 Sell

Rating Trend: Down Down

Today's Overall Ratings:
    Up: 30 | Down: 30 | New: 23
Trade BMRN Now!
Join SI Premium – FREE

Find out which companies are about to raise their dividend well before the news hits the Street with StreetInsider.com's Dividend Insider Elite. Sign-up for a FREE trial here.

Piper Jaffray downgraded BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) from Overweight to Neutral with a price target of $84.00 (from $105.00).

For an analyst ratings summary and ratings history on BioMarin Pharmaceutical Inc. click here. For more ratings news on BioMarin Pharmaceutical Inc. click here.

Shares of BioMarin Pharmaceutical Inc. closed at $82.00 yesterday.

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In

Related Categories

Downgrades, Hot Downgrades

Related Entities

Piper Jaffray

Add Your Comment